Skip to main content
    Z

    Zai Lab Ltd (ZLAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.53
    +0.06 (+0.26%)

    Market Cap: $3.07B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Zai Lab Ltd (ZLAB) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Zai Lab (ZLAB) trades at 6.0x sales and 4.7x book value. Its P/S of 6.0x is below its 5-year median of 71.1x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales6.0x
    Price to book4.7x
    PEGN/A
    FCF yield-7.0%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 87.1% below 36.5x.

    MultipleCurrent5-year median10-year median
    P/S6.0x71.1xN/A
    P/B4.7x25.9x36.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 110 months (10-year).

    Valuation History

    Over the 5 of the 9 year ends shown that have a P/S, its P/S ranged from 4.2x in 2025 to 407.9x in 2021. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$17.644.2x2.7x
    2024$26.1919.1x3.2x
    2023$27.3399.0x33.3x
    2022$30.70136.8x28.2x
    2021$62.85407.9x43.5x
    2020$135.34N/A101.3x
    2019$41.59N/A95.9x
    2018$23.22N/A53.7x
    2017$21.23N/A296.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About ZLAB

    What is ZLAB's price to sales ratio?

    Zai Lab has a price to sales ratio of 6.0x.